Download PDF
Thromb Haemost 1980; 43(02): 095-098
DOI: 10.1055/s-0038-1650025
Original Article
Schattauer GmbH Stuttgart

A Quarter Century with Mr. Hageman[*]

Oscar D Ratnoff M. D.
The Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio, U. S. A.
› Author Affiliations
Further Information

Publication History

Publication Date:
26 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Keywords

Hageman factor - Factor XI - Plasma prekallikrein - High molecular weight kininogen

* The 1979 Wright-Schulte Lecture of the International Society for Thrombosis and Haemostasis. Otherwise unpublished studies were supported in part by Grant HL-01661 from the National Heart, Lung and Blood Institute, the National Institutes of Health, U.S. Public Health Service, and in part by grants from the American Heart Association and its Northest Ohio Affiliate. Plenary lecture held at the VIIth International Congress on Thrombosis and Haemostasis, London, 15-20 July, 1979.


 

  • References

  • 1 Ratnoff OD, Hartmann RC, Conley CL. Studies on a proteolytic enzyme in human plasma. V. The relationship between the proteolytic activity of plasma and blood coagulation. J Exp Med 1950; 91: 123-133
    CrossrefPubMedSearch in Google Scholar
  • 2 Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest 1955; 34: 603-613
    PubMedSearch in Google Scholar
  • 3 Margolius Jr AJ, Ratnoff OD. Observations on the hereditary nature of Hageman trait. Blood 1956; 11: 565-569
    PubMedSearch in Google Scholar
  • 4 Bennett B, Ratnoff OD, Holt JB, Roberts HR. Hageman trait (factor XII deficiency): a probable second genotype inherited as an autosomal dominant characteristic. Blood 1972; 40: 412-415
    PubMedSearch in Google Scholar
  • 5 Smink McL M, Daniel TM, Ratnoff OD, Stavitsky AB. Immunologic demonstration of a deficiency of Hageman factor-like material in Hageman trait. J Lab Clin Med 1967; 69: 819-832
    PubMedSearch in Google Scholar
  • 6 Saito H, Scott JG, Movat HZ, Scialla SJ. Molecular heterogeneity of Hageman trait (factor XII deficiency): evidence that 2 of 49 cases are cross-reacting material positive (CRM+). J Lab Clin Med 1979; 94: 256-265
    PubMedSearch in Google Scholar
  • 7 Glueck HI, Roehill Jr W. Myocardial infarction in a patient with Hageman (factor XII) defect. Ann Int Med 1966; 64: 390-396
    CrossrefPubMedSearch in Google Scholar
  • 8 Hoak JC, Swanson LW, Warner ED, Connor WE. Myocardial infarction associated with severe factor-XII deficiency. Lancet 1966; 2: 884-886
    PubMedSearch in Google Scholar
  • 9 Ratnoff OD, Busse Jr RJ, Sheon RP. The demise of John Hageman. New Engl J Med 1968; 279: 760-761
    CrossrefPubMedSearch in Google Scholar
  • 10 Donaldson VH, McAdams AJ, Stratman EJ, Glueck HI. Fatal vascular disease in a patient with Hageman trait and a connective tissue disorder. New Engl J Med 1977; 297: 1237 (letter)
    PubMedSearch in Google Scholar
  • 11 Biggs R, Sharp AA, Margolis J, Hardisty RM, Stewart J, Davidson WM. Defects in the early stages of blood coagulation: a report of four cases. Brit J Haem 1958; 4: 177-191
    CrossrefPubMedSearch in Google Scholar
  • 12 Soulier J-P, Prou-Wartelle O. New data on Hageman factor and plasma thromboplastin antecedent: the role of 'contact' in the initial phase of blood coagulation. Brit J Haemat 1960; 6: 88-101
    CrossrefPubMedSearch in Google Scholar
  • 13 Ratnoff OD, Rosenblum JM. Role of Hageman factor in the initiation of clotting by glass. Amer J Med 1958; 25: 160-168
    CrossrefPubMedSearch in Google Scholar
  • 14 Schiffman S, Rapaport SI, Ware AG, Mehl JW. Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma. Proc Soc Exp Biol Med 1960; 105: 453-455
    CrossrefPubMedSearch in Google Scholar
  • 15 Kraut H, Frey EK, Bauer E. Über ein neues Kreislaufhormon. II. Mitteilung. Hoppe-Seylers Zeitschr. Physiol. Chem 1928; 175: 97-114
    CrossrefPubMedSearch in Google Scholar
  • 16 Vogt W. Demonstration of the presence of two separate kininforming systems in human and other plasma. In Erdos EG, Back N, Sicuteri F. "Hypotensive Peptides,". New York: Springer Verlag: 1966. pp 185-192
    Search in Google Scholar
  • 17 Jacobsen S, Kriz M. Some data on two purified kininogens from human plasma. Brit J Pharmacol 1967; 29: 25-36
    PubMedSearch in Google Scholar
  • 18 Margolis J. Plasma pain-producing substance and blood clotting. Nature (London) 1957; 180: 1464-1465
    CrossrefPubMedSearch in Google Scholar
  • 19 Webster ME, Ratnoff OD. Role of Hageman factor in the activation of vasodilator activity in human plasma. Nature (London) 1961; 192: 180-181
    CrossrefPubMedSearch in Google Scholar
  • 20 Ratnoff OD. The effect of clotting on the spontaneous activation of plasmin. J Clin Invest 1955; 34: 958-959 (abstr.)
    PubMedSearch in Google Scholar
  • 21 Niewiarowski S, Prou-Wartelle O. Rôle du facteur contact (facteur Hageman) dans la fibrinolyse. Thromb Diath Haemorrh 1959; 3: 593-603
    PubMedSearch in Google Scholar
  • 22 Iatridis SG, Ferguson JH. Effect of surface and Hageman factor on the endogenous or spontaneous activation of the fibrinolytic system. Thromb Diath Haemorrh 1961; 6: 411-423
    PubMedSearch in Google Scholar
  • 23 Ogston D, Ogston CM, Ratnoff OD, Forbes CD. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest 1969; 48: 1786-1801
    CrossrefPubMedSearch in Google Scholar
  • 24 Kaplan AP, Austen KF. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. J Exp Med 1972; 136: 1378-1393
    CrossrefPubMedSearch in Google Scholar
  • 25 Laake K, Vennerod AM. Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma. Thromb Res 1974; 4: 285-302
    CrossrefPubMedSearch in Google Scholar
  • 26 Bouma BM, Griffin JH. Human prekallikrein (plasminogen proactivator): purification, characterization and activation by activated factor XII. Thromb Haemostasis 1977; 38: 136 (abstr.)
    Thieme ConnectPubMedSearch in Google Scholar
  • 27 Vennerod AM, Laake K. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma. Thromb Res 1976; 8: 519-522
    CrossrefPubMedSearch in Google Scholar
  • 28 Mandle Jr R, Kaplan AP. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J Biol Chem 1977; 252: 6097-6104
    PubMedSearch in Google Scholar
  • 29 Saito H. The participation of plasma Thromboplastin antecedent in contact mediated fibrinolysis. Proc Soc exp Biol (in press)
    PubMed
  • 30 Goldsmith Jr GH, Saito H, Ratnoff OD. The activation of plasminogen by Hageman factor (factor XII) and Hageman factor fragments. J Clin Invest 1978; 62: 54-60
    CrossrefPubMedSearch in Google Scholar
  • 31 Schiffman S, Lee P. Partial purification and characterization of contact activation cofactor. J Clin Invest 1975; 56: 1082-1093
    CrossrefPubMedSearch in Google Scholar
  • 32 Schiffman S, Lee P. Preparation, characterization, and activation of a highly purified factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII. Brit J Haemat 1974; 27: 101-114
    CrossrefPubMedSearch in Google Scholar
  • 33 Hathaway WE, Belhasen LP, Hathaway HS. Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood 1965; 26: 521-532
    CrossrefPubMedSearch in Google Scholar
  • 34 Waldman R, Abraham JP, Rebuck JW, Caldwell J, Saito H, Ratnoff OD. Fitzgerald factor: a hitherto unrecognized clotting factor. Lancet 1975; 1: 949-951
    PubMedSearch in Google Scholar
  • 35 Saito H, Ratnoff OD, Waldmann R, Abraham JP. Fitzgerald trait. Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability. J Clin Invest 1975; 55: 1082-1089
    CrossrefPubMedSearch in Google Scholar
  • 36 Wuepper KD. Biochemistry and biology of components of the plasma kinin-forming system. In: Lepow IH, Ward PA. "Inflammation: Mechanisms and Control,". New York: Academic Press: 1972. pp. 93-117
    Search in Google Scholar
  • 37 Wuepper KD, Miller DR, Lacombe M-J. Flaujeac trait. Deficiency of human plasma kininogen. J Clin Invest 1975; 56: 1663-1672
    CrossrefPubMedSearch in Google Scholar
  • 38 Donaldson VH, Glueck HI, Miller MA, Movat HA, Habal F. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. J Lab Clin Med 1976; 87: 327-337
    PubMedSearch in Google Scholar
  • 39 Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavey M, Guimaraes JA, Pierce JV, Kaplan AP. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 1975; 56: 1650-1662
    CrossrefPubMedSearch in Google Scholar
  • 40 Saito H, Ratnoff OD. Molecular heterogeneity of human plasma prekallikrein deficiency (Fletcher trait). Clin Res 1977; 25: 347 A
    PubMedSearch in Google Scholar
  • 41 Donaldson VH, Ratnoff OD. Hageman factor: alterations in physical properties during activation. Science 1965; 150: 754-756
    CrossrefPubMedSearch in Google Scholar
  • 42 Schoenmakers JG G, Matze R, Haanen C, Zilliken F. Hageman factor, a novel sialoglycoprotein with esterase activity. Biochem Biophys Acta 1965; 101: 166-176
    PubMedSearch in Google Scholar
  • 43 Revak SD, Cochrane CP, Johnston AR, Hugli TE. Structural changes accompanying enzymatic activation of human Hageman factor. J Clin Invest 1974; 54: 619-627
    CrossrefPubMedSearch in Google Scholar
  • 44 Kaplan AP, Austen KF. A pre-albumin activator of prekallikrein. J Immunol 1970; 105: 802-811
    PubMedSearch in Google Scholar
  • 45 Fujikawa K, Walsh KA, Davie EW. Isolation and characterization of bovine factor XII (Hageman factor). Biochem 1977; 16: 2270-2278
    CrossrefPubMedSearch in Google Scholar
  • 46 Fujikawa K, Kurachi K, Davie EW. Characterization of bovine factor XIIa (activated Hageman factor). Biochem 1977; 16: 4182-4188
    CrossrefPubMedSearch in Google Scholar
  • 47 Ratnoff OD, Crum JD. Activation of Hageman factor by solutions of ellagic acid. J Lab Clin Med 1964; 63: 359-377
    PubMedSearch in Google Scholar
  • 48 Hardisty RM, Margolis J. The role of Hageman factor in the initiation of blood coagulation. Brit J Haemat 1959; 5: 203-211
    CrossrefPubMedSearch in Google Scholar
  • 49 Vroman L. Effect of hydrophobic surfaces upon blood coagulation. Thromb Diath Haemorrh 1964; 10: 455-493
    PubMedSearch in Google Scholar
  • 50 McMillin CR, Saito H, Ratnoff OD, Walton AG. The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents. J Clin Invest. 1974; 54: 1312-1322
    CrossrefPubMedSearch in Google Scholar
  • 51 Fair BD, Saito H, Ratnoff OD, Rippon WB. Detection by fluorescence of structural changes accompanying the activation of Hageman factor (factor XII). Proc Soc Exp Biol Med 1977; 155: 199-202
    CrossrefPubMedSearch in Google Scholar
  • 52 Revak SD, Cochrane CG, Griffin JH. The binding and cleavage characteristics of human Hageman factor during deficient in factor XI, prekallikrein, or high molecular weight kininogen. J Clin Invest 1977; 59: 1167-1175
    CrossrefPubMedSearch in Google Scholar
  • 53 Ratnoff OD, Saito H. Amidolytic properties of single-chain activated Hageman factor. Proc Natl Acad Sci USA 1979; 76: 1461-1463
    CrossrefPubMedSearch in Google Scholar
  • 54 Ratnoff OD, Saito H. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen and plasma thromboplastin antecedent. Proc Natl Acad Sci USA 1979; 76: 958-961
    CrossrefPubMedSearch in Google Scholar
  • 55 Saito H. Purification of high molecular weight kininogen and the role of this agent in blood coagulation. J Clin Invest 1977; 60: 584-594
    CrossrefPubMedSearch in Google Scholar
  • 56 Schiffman S, Lee P, Waldmann R. Identity of contact activation cofactor and Fitzgerald factor. Thromb Res 1975; 6: 451-454
    CrossrefPubMedSearch in Google Scholar
  • 57 Wiggins RC, Bouma BN, Cochrane CG, Griffin JH. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation factor XI and prekallikrein. Proc Natl Acad Sci 1977; 74: 4636-4640
    CrossrefPubMedSearch in Google Scholar
  • 58 Donaldson VH, Kleniewski J, Saito H, Sayed JK. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. J Clin Invest 1977; 60: 571-583
    CrossrefPubMedSearch in Google Scholar
  • 59 Mandle RJ, Coleman RW, Kaplan AP. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 1976; 73: 4179-4183
    CrossrefPubMedSearch in Google Scholar
  • 60 Thompson RE, Mandle Jr R, Kaplan AP. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest 1977; 60: 1376-1380
    CrossrefPubMedSearch in Google Scholar
  • 61 Ratnoff OD, Saito H. Evidence that Fitzgerald factor counteracts inhibition by kaolin or ellagic acid of the amidolytic properties of a plasma kallikrein. Blood 1976; 47: 243-251
    PubMedSearch in Google Scholar
  • 62 Cochrane CG, Revak SD, Wuepper KD. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med 1973; 138: 1564-1583
    CrossrefPubMedSearch in Google Scholar
  • 63 Ratnoff OD, Saito H. The countervailing effect of high molecular weight (HMW) kininogen upon inhibition by kaolin of Hageman factor (factor XII, HF) and HF fragments (HFf). Blood 52, Suppl 1978; 1: 351 (abstr.)
    PubMedSearch in Google Scholar